Government negotiation of prescription drug prices isn’t a panacea for lower costs
Giving the government the ability to negotiate drug prices would represent a dramatic shift in policy but would fail to generate much in the way of savings.
The Senate Committee on Health, Education, Labor, and Pensions is holding a hearing Tuesday on how the drug delivery system affects what patients pay for prescriptions. With Republican plans for health care reform stalled, and scrutiny surrounding prescription drug costs intensifying, a White House in desperate need of a policy victory may soon sharpen its focus on drug pricing. Since working with Congress on health care is proving to be difficult, President Trump may decide to do it via the executive branch.
One of Donald Trump’s many was “to work on bringing down the cost of medicine by having a fair and
